Isolated left ventricular noncompaction in sub-Saharan Africa: a clinical and echocardiographic perspective

Ferande Peters1, Bijoy K Khandheria, Claudia dos Santos

  • 1Department of Cardiology, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South Africa.

Insights

Isolated left ventricular noncompaction (ILVNC) in Africans often involves both ventricles and is linked to pulmonary hypertension. This study highlights key echocardiographic features in this population.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Genetics

Background:

  • Isolated left ventricular noncompaction (ILVNC) is a rare cardiomyopathy.
  • It results from impaired fetal myocardial compaction, leading to heart failure, arrhythmias, and cardioembolism.
  • Limited data exists on ILVNC's clinical and echocardiographic profile in African populations.

Purpose of the Study:

  • To investigate the clinical and echocardiographic characteristics of ILVNC in African patients.
  • To identify specific features of ILVNC in this demographic.
  • To compare findings with healthy controls of African descent.

Main Methods:

  • A single-center, prospective case-control study.
  • Screening and diagnosis of ILVNC based on specific echocardiographic criteria (LVNC ratio >2, apical trabeculations >3, deep intertrabecular recesses).
  • Inclusion of 54 ILVNC patients and a control group of African descent.

Main Results:

  • The prevalence of ILVNC in the cardiomyopathy clinic was 6.9%.
  • Heart failure with systolic dysfunction (98.1%) was the primary presentation, with reduced ejection fraction (26.7±11.9%).
  • Biventricular abnormalities (right ventricular noncompaction in 22.2%, dilation in 74.1%, depressed function in 59.3%) and pulmonary hypertension (83.3%) were common.

Conclusions:

  • ILVNC in patients of African descent frequently presents with biventricular abnormalities.
  • Pulmonary hypertension is a significant associated finding.
  • These findings expand the understanding of ILVNC beyond isolated left ventricular involvement.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...